The putative mechanism of lymphopenia in CoVID-19 patients  

作　　者：Xinling Wang Zezhong Liu Lu Lu Shibo Jiang 

机构地区：[1]Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),Institute of Infectious Disease and Biosecurity,School of Basic Medical Sciences,Fudan University,Shanghai 200032,China [2]Department of Infectious Diseases and Shenzhen Key Lab of Endogenous Infection,Shenzhen Nanshan People's Hospital and the Sixth Afiliated Hospital of GuangdongMedicalUniversity,Shenzhen 518052,China

出　　处：《Journal of Molecular Cell Biology》2022年第5期1-3,共3页分子细胞生物学报（英文版）

摘　　要：Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)and its variants have caused>5oo million confirmed cases and>6 million deaths.Apart from the common clinical manifestations,63% of admitted coronavirus disease 2019(COvID-19)patients had lymphopenia,increasingto 85% in patients with severe disease(Huang et al.,2020).

关 键 词：PATIENTS admitted lympho 

分 类 号：R563.1[医药卫生—呼吸系统]